OPK

Conviction 82HealthcareScan · Fri, Jun 26, 2026

OPK$1.52+0.66%

ResistanceSupportVol 14

Vol MA14 2.92M

Mar 27Apr 15May 4May 20Jun 9Jun 26

OPKO HEALTH, INC.PHARMACEUTICAL PREPARATIONSwww.opko.com ↗

Price1.52

Change+0.66%

Gap+1.66%

Rel volume2.76×

Avg volume3.09M

Avg $ vol4.48M

SMA 201.44

SMA 501.29

SMA 2001.31

Price vs 50+18.06%

Price vs 200+16.12%

MA stackmixed

50/200 cross—

Supertrendup · 1.35

RSI (14)73

MACD hist0.00

MACD crossbull · 0d

Stoch %K / %D66 / 72

ADX (14)32

+DI / −DI33 / 14

RSI divergence—

MACD divergence—

ATR %+4.28%

ADR %4.67%

52w high1.58

52w low1.10

From 52w high-3.80%

Above 52w low+38.18%

New 52w highNo

SqueezeOn · 2d

Bollinger width9.74%

%B1.06

Donchian pos66.00%

Donchian high1.61

Donchian low1.36

AVWAP (52w high)1.54

vs AVWAP high-1.41%

AVWAP (52w low)1.31

vs AVWAP low+15.61%

OBV trendUp

Chaikin MF (20)-0.12

Today vs 20d2.76×

Avg vol (14d)2.92M

Avg vol (20d)3.09M

Avg $ vol (20d)4.48M

Market cap—

RS 3m (vs SPY)+15.09%

RS 6m (vs SPY)+6.31%

RS line new highYes

Trend template6/8

Technical rank82.2

1 week+7.04%

1 month+16.92%

3 months+29.91%

6 months+16.03%

1 year+19.69%

YTD+19.69%

P/E-5.04

P/B0.94

P/S1.87

P/FCF-5.96

EPS-0.3000

Div yield—

ROE-18.73%

ROA-12.15%

Debt/Eq0.00

Current3.61

EV/EBITDA-31.34

Gross margin33.93%

Net margin-37.19%

Rev growth-14.90%

EPS growth-324.02%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value808.09M

Revenue124.2M

Net income-54.85M

Gross profit45.76M

Free cash flow-190.82M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out755.09M

Employees2.27K

ListedThu, Nov 2, 1995

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction82 / 100

Pattern quality—

Tech rank82.2 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.53

Support1.08

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in OPK

All disclosures →

No recent disclosed trades by Congress in OPK. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in OPK · 6 buys

Insider	Side	Shares	Value	Traded	Filed
MEDEL ROGER MD Director · Stock Option (Right to Buy) · 2026-06-18	Grant	30K	—	2026-06-18	2026-06-22
UPPALURI SUBBARAO V Director · Stock Option (Right to Buy) · 2026-06-18	Grant	80K	—	2026-06-18	2026-06-22
Lachman Prem A Director · Stock Option (Right to Buy) · 2026-06-18	Grant	30K	—	2026-06-18	2026-06-22
Yu Alice Lin-Tsing Director · Stock Option (Right to Buy) · 2026-06-18	Grant	30K	—	2026-06-18	2026-06-22
PFENNIGER RICHARD C JR Director · Stock Option (Right to Buy) · 2026-06-18	Grant	60K	—	2026-06-18	2026-06-22
PAGANELLI JOHN A Director · Stock Option (Right to Buy) · 2026-06-18	Grant	30K	—	2026-06-18	2026-06-22

SEC filings

EDGAR filings in OPK · 1 recent

EDGAR →

8-K8-KThu, Jun 18, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.